By editing blood stem cells, researchers show that the immune system itself can be transformed into a durable, boostable source of therapeutic proteins—opening the door to novel treatments
Researchers created the first mouse model in which chronic viral infection progresses to liver cancer, closely mirroring what happens in people with hepatitis C.
The Rockefeller teams will map immune cell interactions, engineer cells as drug delivery systems, and activate immune responses in hard-to-treat cancers.
Theodora Hatziioannou used her expertise on HIV-1 to gain insights into SARS-Co-V-2, and vice versa. The potential applications of her insights could be much broader.
Researchers used a combination of wet lab research and deep machine learning to pinpoint distinct genetic sequences, work that could inform therapeutic strategies for chronic inflammation.
Long thought to serve as cellular scaffolding, microtubules also reshape the proteins that bind to them—guiding enzyme activity to prevent genetic errors linked to cancer.
